The global Biosimilar of Remicade market was valued at US$ 299000 million in 2023 and is anticipated to reach US$ 491720 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.

Biosimilar of Remicade Market

A biosimilar of Remicade is a biologic medication that is highly similar to the reference product, Remicade, in terms of safety, efficacy, and quality.

The market for biosimilars of Remicade is driven by the increasing adoption of biosimilar therapies and the need for affordable treatment options for autoimmune diseases. The market's growth is also influenced by the presence of well-established regulatory pathways for biosimilar approval and the entry of multiple biosimilar manufacturers into the market.

This report aims to provide a comprehensive presentation of the global market for Biosimilar of Remicade, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilar of Remicade.

Report Scope

The Biosimilar of Remicade market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biosimilar of Remicade market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biosimilar of Remicade companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biosimilar of Remicade Market Report

Report Metric	Details
Report Name	Biosimilar of Remicade Market
Accounted market size in 2023	US$ 299000 million
Forecasted market size in 2030	US$ 491720 million
CAGR	7.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Monoclonal Antibodies Interferon Erythropoietin Insulin Vaccines Other
Segment by Application	Tumor Diabetes Cardiovascular Hemophilia Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biosimilar of Remicade companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biosimilar of Remicade Market growing?

Ans: The Biosimilar of Remicade Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Biosimilar of Remicade Market size in 2030?

Ans: The Biosimilar of Remicade Market size in 2030 will be US$ 491720 million.

Who are the main players in the Biosimilar of Remicade Market report?

Ans: The main players in the Biosimilar of Remicade Market are Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly, Novartis, Merck, 3sbio, Changchun High Tech, CP Guojian, Biotech, Gelgen, Innovent, Dong Bao, Ganlee, United Laboratories

What are the Application segmentation covered in the Biosimilar of Remicade Market report?

Ans: The Applications covered in the Biosimilar of Remicade Market report are Tumor, Diabetes, Cardiovascular, Hemophilia, Other

What are the Type segmentation covered in the Biosimilar of Remicade Market report?

Ans: The Types covered in the Biosimilar of Remicade Market report are Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Erythropoietin

1.2.5 Insulin

1.2.6 Vaccines

1.2.7 Other

1.3 Market by Application

1.3.1 Global Biosimilar of Remicade Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biosimilar of Remicade Market Perspective (2019-2030)

2.2 Biosimilar of Remicade Growth Trends by Region

2.2.1 Global Biosimilar of Remicade Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biosimilar of Remicade Historic Market Size by Region (2019-2024)

2.2.3 Biosimilar of Remicade Forecasted Market Size by Region (2025-2030)

2.3 Biosimilar of Remicade Market Dynamics

2.3.1 Biosimilar of Remicade Industry Trends

2.3.2 Biosimilar of Remicade Market Drivers

2.3.3 Biosimilar of Remicade Market Challenges

2.3.4 Biosimilar of Remicade Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biosimilar of Remicade Players by Revenue

3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2019-2024)

3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2019-2024)

3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biosimilar of Remicade Revenue

3.4 Global Biosimilar of Remicade Market Concentration Ratio

3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2023

3.5 Biosimilar of Remicade Key Players Head office and Area Served

3.6 Key Players Biosimilar of Remicade Product Solution and Service

3.7 Date of Enter into Biosimilar of Remicade Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar of Remicade Breakdown Data by Type

4.1 Global Biosimilar of Remicade Historic Market Size by Type (2019-2024)

4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2025-2030)

5 Biosimilar of Remicade Breakdown Data by Application

5.1 Global Biosimilar of Remicade Historic Market Size by Application (2019-2024)

5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biosimilar of Remicade Market Size (2019-2030)

6.2 North America Biosimilar of Remicade Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biosimilar of Remicade Market Size by Country (2019-2024)

6.4 North America Biosimilar of Remicade Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biosimilar of Remicade Market Size (2019-2030)

7.2 Europe Biosimilar of Remicade Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biosimilar of Remicade Market Size by Country (2019-2024)

7.4 Europe Biosimilar of Remicade Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biosimilar of Remicade Market Size (2019-2030)

8.2 Asia-Pacific Biosimilar of Remicade Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biosimilar of Remicade Market Size by Region (2019-2024)

8.4 Asia-Pacific Biosimilar of Remicade Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biosimilar of Remicade Market Size (2019-2030)

9.2 Latin America Biosimilar of Remicade Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biosimilar of Remicade Market Size by Country (2019-2024)

9.4 Latin America Biosimilar of Remicade Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biosimilar of Remicade Market Size (2019-2030)

10.2 Middle East & Africa Biosimilar of Remicade Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biosimilar of Remicade Market Size by Country (2019-2024)

10.4 Middle East & Africa Biosimilar of Remicade Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Biosimilar of Remicade Introduction

11.1.4 Roche Revenue in Biosimilar of Remicade Business (2019-2024)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Detail

11.2.2 Amgen Business Overview

11.2.3 Amgen Biosimilar of Remicade Introduction

11.2.4 Amgen Revenue in Biosimilar of Remicade Business (2019-2024)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biosimilar of Remicade Introduction

11.3.4 AbbVie Revenue in Biosimilar of Remicade Business (2019-2024)

11.3.5 AbbVie Recent Development

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Detail

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Biosimilar of Remicade Introduction

11.4.4 Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2019-2024)

11.4.5 Sanofi-Aventis Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biosimilar of Remicade Introduction

11.5.4 Johnson & Johnson Revenue in Biosimilar of Remicade Business (2019-2024)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biosimilar of Remicade Introduction

11.6.4 Pfizer Revenue in Biosimilar of Remicade Business (2019-2024)

11.6.5 Pfizer Recent Development

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Detail

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Biosimilar of Remicade Introduction

11.7.4 Novo Nordisk Revenue in Biosimilar of Remicade Business (2019-2024)

11.7.5 Novo Nordisk Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Detail

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Biosimilar of Remicade Introduction

11.8.4 Eli Lilly Revenue in Biosimilar of Remicade Business (2019-2024)

11.8.5 Eli Lilly Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis Biosimilar of Remicade Introduction

11.9.4 Novartis Revenue in Biosimilar of Remicade Business (2019-2024)

11.9.5 Novartis Recent Development

11.10 Merck

11.10.1 Merck Company Detail

11.10.2 Merck Business Overview

11.10.3 Merck Biosimilar of Remicade Introduction

11.10.4 Merck Revenue in Biosimilar of Remicade Business (2019-2024)

11.10.5 Merck Recent Development

11.11 3sbio

11.11.1 3sbio Company Detail

11.11.2 3sbio Business Overview

11.11.3 3sbio Biosimilar of Remicade Introduction

11.11.4 3sbio Revenue in Biosimilar of Remicade Business (2019-2024)

11.11.5 3sbio Recent Development

11.12 Changchun High Tech

11.12.1 Changchun High Tech Company Detail

11.12.2 Changchun High Tech Business Overview

11.12.3 Changchun High Tech Biosimilar of Remicade Introduction

11.12.4 Changchun High Tech Revenue in Biosimilar of Remicade Business (2019-2024)

11.12.5 Changchun High Tech Recent Development

11.13 CP Guojian

11.13.1 CP Guojian Company Detail

11.13.2 CP Guojian Business Overview

11.13.3 CP Guojian Biosimilar of Remicade Introduction

11.13.4 CP Guojian Revenue in Biosimilar of Remicade Business (2019-2024)

11.13.5 CP Guojian Recent Development

11.14 Biotech

11.14.1 Biotech Company Detail

11.14.2 Biotech Business Overview

11.14.3 Biotech Biosimilar of Remicade Introduction

11.14.4 Biotech Revenue in Biosimilar of Remicade Business (2019-2024)

11.14.5 Biotech Recent Development

11.15 Gelgen

11.15.1 Gelgen Company Detail

11.15.2 Gelgen Business Overview

11.15.3 Gelgen Biosimilar of Remicade Introduction

11.15.4 Gelgen Revenue in Biosimilar of Remicade Business (2019-2024)

11.15.5 Gelgen Recent Development

11.16 Innovent

11.16.1 Innovent Company Detail

11.16.2 Innovent Business Overview

11.16.3 Innovent Biosimilar of Remicade Introduction

11.16.4 Innovent Revenue in Biosimilar of Remicade Business (2019-2024)

11.16.5 Innovent Recent Development

11.17 Dong Bao

11.17.1 Dong Bao Company Detail

11.17.2 Dong Bao Business Overview

11.17.3 Dong Bao Biosimilar of Remicade Introduction

11.17.4 Dong Bao Revenue in Biosimilar of Remicade Business (2019-2024)

11.17.5 Dong Bao Recent Development

11.18 Ganlee

11.18.1 Ganlee Company Detail

11.18.2 Ganlee Business Overview

11.18.3 Ganlee Biosimilar of Remicade Introduction

11.18.4 Ganlee Revenue in Biosimilar of Remicade Business (2019-2024)

11.18.5 Ganlee Recent Development

11.19 United Laboratories

11.19.1 United Laboratories Company Detail

11.19.2 United Laboratories Business Overview

11.19.3 United Laboratories Biosimilar of Remicade Introduction

11.19.4 United Laboratories Revenue in Biosimilar of Remicade Business (2019-2024)

11.19.5 United Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Biosimilar of Remicade Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Interferon

Table 4. Key Players of Erythropoietin

Table 5. Key Players of Insulin

Table 6. Key Players of Vaccines

Table 7. Key Players of Other

Table 8. Global Biosimilar of Remicade Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Biosimilar of Remicade Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Biosimilar of Remicade Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Biosimilar of Remicade Market Share by Region (2019-2024)

Table 12. Global Biosimilar of Remicade Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Biosimilar of Remicade Market Share by Region (2025-2030)

Table 14. Biosimilar of Remicade Market Trends

Table 15. Biosimilar of Remicade Market Drivers

Table 16. Biosimilar of Remicade Market Challenges

Table 17. Biosimilar of Remicade Market Restraints

Table 18. Global Biosimilar of Remicade Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Biosimilar of Remicade Market Share by Players (2019-2024)

Table 20. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2023)

Table 21. Ranking of Global Top Biosimilar of Remicade Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Biosimilar of Remicade Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Biosimilar of Remicade Product Solution and Service

Table 25. Date of Enter into Biosimilar of Remicade Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Biosimilar of Remicade Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Biosimilar of Remicade Revenue Market Share by Type (2019-2024)

Table 29. Global Biosimilar of Remicade Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Biosimilar of Remicade Revenue Market Share by Type (2025-2030)

Table 31. Global Biosimilar of Remicade Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Biosimilar of Remicade Revenue Market Share by Application (2019-2024)

Table 33. Global Biosimilar of Remicade Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Biosimilar of Remicade Revenue Market Share by Application (2025-2030)

Table 35. North America Biosimilar of Remicade Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Biosimilar of Remicade Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Biosimilar of Remicade Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Biosimilar of Remicade Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Biosimilar of Remicade Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Biosimilar of Remicade Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Biosimilar of Remicade Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Biosimilar of Remicade Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Biosimilar of Remicade Market Size by Country (2025-2030) & (US$ Million)

Table 50. Roche Company Detail

Table 51. Roche Business Overview

Table 52. Roche Biosimilar of Remicade Product

Table 53. Roche Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 54. Roche Recent Development

Table 55. Amgen Company Detail

Table 56. Amgen Business Overview

Table 57. Amgen Biosimilar of Remicade Product

Table 58. Amgen Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 59. Amgen Recent Development

Table 60. AbbVie Company Detail

Table 61. AbbVie Business Overview

Table 62. AbbVie Biosimilar of Remicade Product

Table 63. AbbVie Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 64. AbbVie Recent Development

Table 65. Sanofi-Aventis Company Detail

Table 66. Sanofi-Aventis Business Overview

Table 67. Sanofi-Aventis Biosimilar of Remicade Product

Table 68. Sanofi-Aventis Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 69. Sanofi-Aventis Recent Development

Table 70. Johnson & Johnson Company Detail

Table 71. Johnson & Johnson Business Overview

Table 72. Johnson & Johnson Biosimilar of Remicade Product

Table 73. Johnson & Johnson Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 74. Johnson & Johnson Recent Development

Table 75. Pfizer Company Detail

Table 76. Pfizer Business Overview

Table 77. Pfizer Biosimilar of Remicade Product

Table 78. Pfizer Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 79. Pfizer Recent Development

Table 80. Novo Nordisk Company Detail

Table 81. Novo Nordisk Business Overview

Table 82. Novo Nordisk Biosimilar of Remicade Product

Table 83. Novo Nordisk Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 84. Novo Nordisk Recent Development

Table 85. Eli Lilly Company Detail

Table 86. Eli Lilly Business Overview

Table 87. Eli Lilly Biosimilar of Remicade Product

Table 88. Eli Lilly Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 89. Eli Lilly Recent Development

Table 90. Novartis Company Detail

Table 91. Novartis Business Overview

Table 92. Novartis Biosimilar of Remicade Product

Table 93. Novartis Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 94. Novartis Recent Development

Table 95. Merck Company Detail

Table 96. Merck Business Overview

Table 97. Merck Biosimilar of Remicade Product

Table 98. Merck Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 99. Merck Recent Development

Table 100. 3sbio Company Detail

Table 101. 3sbio Business Overview

Table 102. 3sbio Biosimilar of Remicade Product

Table 103. 3sbio Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 104. 3sbio Recent Development

Table 105. Changchun High Tech Company Detail

Table 106. Changchun High Tech Business Overview

Table 107. Changchun High Tech Biosimilar of Remicade Product

Table 108. Changchun High Tech Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 109. Changchun High Tech Recent Development

Table 110. CP Guojian Company Detail

Table 111. CP Guojian Business Overview

Table 112. CP Guojian Biosimilar of Remicade Product

Table 113. CP Guojian Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 114. CP Guojian Recent Development

Table 115. Biotech Company Detail

Table 116. Biotech Business Overview

Table 117. Biotech Biosimilar of Remicade Product

Table 118. Biotech Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 119. Biotech Recent Development

Table 120. Gelgen Company Detail

Table 121. Gelgen Business Overview

Table 122. Gelgen Biosimilar of Remicade Product

Table 123. Gelgen Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 124. Gelgen Recent Development

Table 125. Innovent Company Detail

Table 126. Innovent Business Overview

Table 127. Innovent Biosimilar of Remicade Product

Table 128. Innovent Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 129. Innovent Recent Development

Table 130. Dong Bao Company Detail

Table 131. Dong Bao Business Overview

Table 132. Dong Bao Biosimilar of Remicade Product

Table 133. Dong Bao Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 134. Dong Bao Recent Development

Table 135. Ganlee Company Detail

Table 136. Ganlee Business Overview

Table 137. Ganlee Biosimilar of Remicade Product

Table 138. Ganlee Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 139. Ganlee Recent Development

Table 140. United Laboratories Company Detail

Table 141. United Laboratories Business Overview

Table 142. United Laboratories Biosimilar of Remicade Product

Table 143. United Laboratories Revenue in Biosimilar of Remicade Business (2019-2024) & (US$ Million)

Table 144. United Laboratories Recent Development

Table 145. Research Programs/Design for This Report

Table 146. Key Data Information from Secondary Sources

Table 147. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biosimilar of Remicade Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biosimilar of Remicade Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Interferon Features

Figure 5. Erythropoietin Features

Figure 6. Insulin Features

Figure 7. Vaccines Features

Figure 8. Other Features

Figure 9. Global Biosimilar of Remicade Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Biosimilar of Remicade Market Share by Application: 2023 VS 2030

Figure 11. Tumor Case Studies

Figure 12. Diabetes Case Studies

Figure 13. Cardiovascular Case Studies

Figure 14. Hemophilia Case Studies

Figure 15. Other Case Studies

Figure 16. Biosimilar of Remicade Report Years Considered

Figure 17. Global Biosimilar of Remicade Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 18. Global Biosimilar of Remicade Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 19. Global Biosimilar of Remicade Market Share by Region: 2023 VS 2030

Figure 20. Global Biosimilar of Remicade Market Share by Players in 2023

Figure 21. Global Top Biosimilar of Remicade Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar of Remicade as of 2023)

Figure 22. The Top 10 and 5 Players Market Share by Biosimilar of Remicade Revenue in 2023

Figure 23. North America Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. North America Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 25. United States Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Canada Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Europe Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Europe Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 29. Germany Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Asia-Pacific Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Asia-Pacific Biosimilar of Remicade Market Share by Region (2019-2030)

Figure 37. China Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Japan Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. South Korea Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. India Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Australia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Latin America Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Latin America Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 45. Mexico Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Brazil Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East & Africa Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Biosimilar of Remicade Market Share by Country (2019-2030)

Figure 49. Turkey Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Biosimilar of Remicade Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 51. Roche Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 52. Amgen Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 53. AbbVie Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 54. Sanofi-Aventis Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 55. Johnson & Johnson Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 57. Novo Nordisk Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 58. Eli Lilly Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 59. Novartis Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 60. Merck Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 61. 3sbio Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 62. Changchun High Tech Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 63. CP Guojian Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 64. Biotech Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 65. Gelgen Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 66. Innovent Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 67. Dong Bao Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 68. Ganlee Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 69. United Laboratories Revenue Growth Rate in Biosimilar of Remicade Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-36S14110

Thu May 02 00:00:00 UTC 2024

Add to Cart

High Capacity Endotoxin Removal Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14G14630

Thu May 02 00:00:00 UTC 2024

Add to Cart

Rapid Endotoxin Removal Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-7R14828

Thu May 02 00:00:00 UTC 2024

Add to Cart

Automated Complete Blood Cell Counter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-38S14317

Thu May 02 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Biosimilar of Remicade Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-25X1659

Global Biosimilar of Remicade Market Research Report 2024

FEATURED COMPANIES

Biosimilar of Remicade Market Size

Biosimilar of Remicade Market

Report Scope

Scope of Biosimilar of Remicade Market Report

Chapter Outline

FAQ for this report

How fast is Biosimilar of Remicade Market growing?

What is the Biosimilar of Remicade Market size in 2030?

Who are the main players in the Biosimilar of Remicade Market report?

What are the Application segmentation covered in the Biosimilar of Remicade Market report?

What are the Type segmentation covered in the Biosimilar of Remicade Market report?

FEATURED COMPANIES

RELATED REPORTS